Exodus Point Capital Management, LP Prelude Therapeutics Inc Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$6.9 - $13.22 $143,333 - $274,619
-20,773 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$11.89 - $31.74 $246,990 - $659,335
20,773 New
20,773 $259,000
Q4 2020

Feb 16, 2021
SELL
$28.81 - $88.94 $204,781 - $632,185
-7,108 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$26.2 - $30.13 $186,229 - $214,164
7,108 New
7,108 $214,000

Others Institutions Holding PRLD

# of Institutions
59
Shares Held
34.2M
Call Options Held
200
Put Options Held
0
View Full List

About Prelude Therapeutics Inc

PRLD Quotes by TradingView
  • Ticker PRLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,369,200
  • Market Cap $131M
  • Description
  • Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...
More about PRLD
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email